Ansofaxine
Ansofaxine[edit | edit source]
Ansofaxine, also known as LY03005, is a novel antidepressant that functions as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It is being developed for the treatment of major depressive disorder (MDD) and other mood disorders. Ansofaxine is notable for its triple reuptake inhibition, which distinguishes it from other antidepressants that typically target only one or two of these neurotransmitters.
Mechanism of Action[edit | edit source]
Ansofaxine works by inhibiting the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine. This action increases the levels of these neurotransmitters in the synaptic cleft, enhancing neurotransmission and improving mood and emotional regulation. The balanced reuptake inhibition is thought to contribute to its efficacy in treating depressive symptoms.
Clinical Development[edit | edit source]
Ansofaxine is currently undergoing clinical trials to evaluate its safety and efficacy. Early studies have shown promise in reducing symptoms of depression with a favorable side effect profile. The drug is being developed by Luye Pharma Group, and it represents a potential new option for patients who do not respond adequately to existing antidepressants.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Ansofaxine includes rapid absorption and a relatively long half-life, which supports once-daily dosing. It is metabolized primarily in the liver and excreted through the kidneys. Understanding the pharmacokinetics is crucial for optimizing dosing regimens and minimizing potential drug interactions.
Side Effects[edit | edit source]
Common side effects of Ansofaxine may include nausea, headache, insomnia, and dry mouth. As with other antidepressants, there is a risk of serotonin syndrome if taken in combination with other serotonergic agents. Patients should be monitored for any adverse effects, especially during the initial phase of treatment.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
